Oligodendroglioma

Showing 1 - 25 of 41

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Diffuse Glioma Based on Deep Learning

Recruiting
  • Astrocytoma
  • +2 more
  • multi-parametric magnetic resonance imaging scan
  • Pathology examination
  • Nanjing, Jiangsu, China
    Department of Radiology, the Affiliated Drum Tower Hospital of N
Nov 21, 2022

High-grade Glioma, Oligodendroglioma, Astrocytoma Trial (Low-dose OKN-007, BID, Low-dose OKN-007, TID, Mid-dose OKN-007, TID)

Not yet recruiting
  • High-grade Glioma
  • +3 more
  • Low-dose OKN-007, BID
  • +3 more
  • (no location specified)
Sep 26, 2022

Astrocytoma, Glioblastoma, Oligodendroglioma Trial in Atlanta (Craniotomy, Quantitative Oblique Back-Illumination Microscopy)

Not yet recruiting
  • Astrocytoma
  • +2 more
  • Craniotomy
  • Quantitative Oblique Back-Illumination Microscopy
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 22, 2022

Oligodendroglioma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)

Recruiting
  • Oligodendroglioma
  • Tislelizumab plus Bevacizumab
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Aug 21, 2022

Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)

Not yet recruiting
  • Glioma
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 22, 2022

Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)

Recruiting
  • Glioma
  • +8 more
  • MRI-guided laser ablation
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 22, 2022

Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion Trial in France (PCV chemo, Radiotherapy and PCV chemo)

Recruiting
  • Oligodendroglioma
  • +2 more
  • PCV chemotherapy
  • Radiotherapy and PCV chemotherapy
  • Amiens, France
  • +25 more
Jun 14, 2022

Oligodendroglioma Trial in Germany (CETEG, PCV, RT)

Recruiting
  • Oligodendroglioma
  • Heidelberg, Baden-Württemberg, Germany
  • +18 more
Apr 11, 2022

Astrocytoma, Ependymoma, Ganglioglioma Trial in Maastricht, Delft, Groningen (ProTRAIT)

Recruiting
  • Astrocytoma
  • +11 more
  • ProTRAIT
  • Maastricht, Limburg, Netherlands
  • +2 more
Apr 12, 2022

CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

Recruiting
  • Central Nervous System Neoplasms
  • +22 more
  • Bethesda, Maryland
    National Institutes of Health
Mar 1, 2022

Oligodendroglioma, Oligodendroglioma, Anaplastic, Diffuse Astrocytoma, IDH-Mutant Trial in Oslo (Radiation therapy)

Recruiting
  • Oligodendroglioma
  • +2 more
  • Radiation therapy
  • Oslo, Norway
    Oslo University Hospital
Jan 14, 2022

Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

Active, not recruiting
  • Oligodendroglioma
  • +5 more
  • GBM6-AD and poly-ICLC before and after surgery
  • GBM6-AD and poly-ICLC after surgery only
  • San Francisco, California
    University of California
Nov 15, 2021

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2021

Qualitative, Qualitative, and Functional Studies Over First Year

Completed
  • Astrocytoma
  • +2 more
  • Hepatitis A Vaccine
  • +3 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Oct 28, 2021

Glioblastoma, Astrocytoma, Oligodendroglioma Trial (OKN-007)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • (no location specified)
Sep 26, 2021

Educating Brain Tumor Patients Using Patient-specific

Recruiting
  • Brain Tumor
  • +7 more
  • Three-dimensional printed model
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Jul 10, 2021

MicroRNA-10b in Patients With Gliomas

Recruiting
  • Astrocytoma
  • +8 more
    • Boston, Massachusetts
    • +3 more
    May 30, 2021

    Proteomic Characterization of Aggressive Oligodendrogliomas

    Recruiting
    • Oligodendroglioma
    • Proteomic analysis
    • Bron, France
    • +1 more
    Apr 12, 2021

    Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life

    Withdrawn
    • Anaplastic Oligodendroglioma
    • +2 more
    • Wear novoTTF-200A
    • Quality-of-Life Assessment
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Dec 8, 2020

    The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo

    Recruiting
    • Cancer, All Types
    • +44 more
      • Gainesville, Georgia
        Specicare
      Dec 2, 2020

      Oligoastrocytoma, Astrocytoma, Oligodendroglioma Trial (device, procedure, other)

      Completed
      • Oligoastrocytoma
      • +2 more
      • fMRI
      • +2 more
      • (no location specified)
      Sep 1, 2020

      Giant Cell Glioblastoma, Gliosarcoma, Oligodendroglioma Trial in Los Angeles (autologous dendritic cells pulsed with tumor

      Withdrawn
      • Giant Cell Glioblastoma
      • +4 more
      • autologous dendritic cells pulsed with tumor lysate antigen Vaccine
      • +4 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Jul 22, 2020

      Astrocytoma, Oligodendroglioma, Oligodendroastrocytoma Trial in Guangzhou (Radiotherapy, Temozolomide)

      Recruiting
      • Astrocytoma
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      May 26, 2020

      Oligodendroglioma, Oligoastrocytoma Trial in Spain (Palbociclib)

      Completed
      • Oligodendroglioma
      • Oligoastrocytoma
      • Las Palmas de Gran Canaria, Las Palmas, Spain
      • +10 more
      Apr 1, 2020

      Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes

      Recruiting
      • Astrocytoma, Grade II
      • +3 more
        • Rotterdam, Zuid Holland, Netherlands
        • +4 more
        Mar 23, 2020